These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10090578)

  • 1. The combination of topical ceftazidime and aminoglycosides in the treatment of refractory pseudomonal keratitis.
    Robinson A; Kremer I; Avisar R; Gaton D; Savir H; Yassur Y
    Graefes Arch Clin Exp Ophthalmol; 1999 Mar; 237(3):177-80. PubMed ID: 10090578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination intravenous ceftazidime and aminoglycosides in the treatment of pseudomonal scleritis.
    Helm CJ; Holland GN; Webster RG; Maloney RK; Mondino BJ
    Ophthalmology; 1997 May; 104(5):838-43. PubMed ID: 9160031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa.
    Rhee MK; Kowalski RP; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
    Am J Ophthalmol; 2004 Aug; 138(2):226-30. PubMed ID: 15289131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group.
    O'Brien TP; Maguire MG; Fink NE; Alfonso E; McDonnell P
    Arch Ophthalmol; 1995 Oct; 113(10):1257-65. PubMed ID: 7575256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of topical ceftazidime on pseudomonas keratitis in rabbits.
    Kremer I; Robinson A; Braffman M; Drucker M; Goldenfeld M; Samra Z; Myszne-Daye N; Gaton D; Savir H
    Cornea; 1994 Jul; 13(4):360-3. PubMed ID: 7924338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Value of Fortified Aminoglycoside/Cephalosporin Treatment as First-Line Treatment and in Fluoroquinolone-Resistant Bacterial Keratitis.
    Dikmetaş Ö; Deniz Y; Kocabeyoğlu S; Başol M; İrkeç M
    Turk J Ophthalmol; 2020 Oct; 50(5):258-263. PubMed ID: 33342191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group.
    Hyndiuk RA; Eiferman RA; Caldwell DR; Rosenwasser GO; Santos CI; Katz HR; Badrinath SS; Reddy MK; Adenis JP; Klauss V
    Ophthalmology; 1996 Nov; 103(11):1854-62; discussion 1862-3. PubMed ID: 8942881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical ciprofloxacin versus topical fortified antibiotics in rabbit models of Staphylococcus and Pseudomonas keratitis.
    Lauffenburger MD; Cohen KL
    Cornea; 1993 Nov; 12(6):517-21. PubMed ID: 8261784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis.
    Bu P; Riske PS; Zaya NE; Carey R; Bouchard CS
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):213-20. PubMed ID: 17593004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ciprofloxacin-resistant Pseudomonas keratitis.
    Garg P; Sharma S; Rao GN
    Ophthalmology; 1999 Jul; 106(7):1319-23. PubMed ID: 10406614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis.
    Panda A; Ahuja R; Sastry SS
    Eye (Lond); 1999 Dec; 13 ( Pt 6)():744-7. PubMed ID: 10707137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of clinical characteristics and antibiotic susceptibility between Pseudomonas aeruginosa and P. putida keratitis at a tertiary referral center: a retrospective study.
    Cho CH; Lee SB
    BMC Ophthalmol; 2018 Aug; 18(1):204. PubMed ID: 30126384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of the first contact management profile of cases of infectious keratitis: a hospital-based study.
    Vajpayee RB; Dada T; Saxena R; Vajpayee M; Taylor HR; Venkatesh P; Sharma N
    Cornea; 2000 Jan; 19(1):52-6. PubMed ID: 10632009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Pseudomonas keratitis in humans.
    Hessburg PC
    Am J Ophthalmol; 1966 May; 61(5 Pt 1):896-903. PubMed ID: 16874993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late-onset Pseudomonas keratitis after radial keratotomy and subsequent laser in situ keratomileusis: case report and literature review.
    Levy J; Hirsh A; Klemperer I; Lifshitz T
    Can J Ophthalmol; 2005 Apr; 40(2):211-3. PubMed ID: 16049542
    [No Abstract]   [Full Text] [Related]  

  • 16. A case of bilateral keratitis caused by Providencia alcalifaciens: a rarely encountered ocular pathogen.
    Choi W; Ji YS; Yoon KC
    Int Ophthalmol; 2018 Jun; 38(3):1325-1328. PubMed ID: 28516225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of topical 0.3% ofloxacin to fortified tobramycin-cefazolin in the therapy of bacterial keratitis.
    Khokhar S; Sindhu N; Mirdha BR
    Infection; 2000; 28(3):149-52. PubMed ID: 10879638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of specific antibiotic/steroid combinations for therapy of experimental Pseudomonas aeruginosa keratitis.
    Engel LS; Callegan MC; Hobden JA; Reidy JJ; Hill JM; O'Callaghan RJ
    Curr Eye Res; 1995 Mar; 14(3):229-34. PubMed ID: 7796606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiresistant Pseudomonas keratitis.
    Ku JY; Kim P; Tong J; Wechsler A; McCluskey P
    Clin Exp Ophthalmol; 2010 Nov; 38(8):818-9. PubMed ID: 20572829
    [No Abstract]   [Full Text] [Related]  

  • 20. Effectiveness of mupirocin and polymyxin B in experimental Staphylococcus aureus, Pseudomonas aeruginosa, and Serratia marcescens keratitis.
    Moreau JM; Conerly LL; Hume EB; Dajcs JJ; Girgis DO; Cannon BM; Thibodeaux BA; Stroman DW; O'Callaghan RJ
    Cornea; 2002 Nov; 21(8):807-11. PubMed ID: 12410042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.